SHPH
NASDAQ · Biotechnology
Shuttle Pharmaceuticals Hold
$0.60
+0.06 (+11.59%)
Financial Highlights (FY 2025)
Revenue
3.31M
Net Income
119.2K
Gross Margin
63.2%
Profit Margin
3.6%
Rev Growth
+15.9%
D/E Ratio
0.66
Revenue & Net Income
Margin Trends
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Gross Margin | 63.2% | 63.2% | 63.2% |
| Operating Margin | 4.2% | 4.5% | 4.6% |
| Profit Margin | 3.6% | 3.3% | 3.3% |
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.31M | 2.94M | 3.37M |
| Gross Profit | 2.09M | 1.86M | 2.13M |
| Operating Income | 138.0K | 133.0K | 154.0K |
| Net Income | 119.2K | 97.1K | 110.6K |
| Gross Margin | 63.2% | 63.2% | 63.2% |
| Operating Margin | 4.2% | 4.5% | 4.6% |
| Profit Margin | 3.6% | 3.3% | 3.3% |
| Rev Growth | +15.9% | +11.7% | +12.8% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 1.18M | 1.33M | 1.17M |
| Total Equity | 1.80M | 1.81M | 1.77M |
| D/E Ratio | 0.66 | 0.73 | 0.66 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 181.4K | 163.4K | 177.0K |
| Free Cash Flow | 96.2K | 133.1K | 131.3K |